SCHEMBL5505233

SCHEMBL5505233

C=CC(=O)NCCCNc1cc2c(Nc3ccc(F)c(F)c3F)ncnc2cc1OC(C)C1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.55
KDR P35968 19/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509401 0.91 EGFR (0.59) EGFRKDR
SCHEMBL5505229 0.87 EGFR (0.60) EGFRKDR
SCHEMBL5518663 0.85 EGFR (0.59) EGFRKDR
SCHEMBL5508423 0.83 EGFR (0.58) EGFRKDR
SCHEMBL5512759 0.83 EGFR (0.56) EGFRKDR
SCHEMBL4578654 0.81 EGFR (0.63) EGFRKDR
SCHEMBL5512911 0.81 EGFR (0.69) EGFRKDR
SCHEMBL5511536 0.81 EGFR (0.62) EGFRKDR
SCHEMBL5511493 0.78 KDR (0.48) EGFRKDR
SCHEMBL4579864 0.77 EGFR (0.78) EGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007055513-A1 QUINAZOLINE DERIVATIVES AS A SIGNAL TRANSDUCTION INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2007-05-18 WO claimed
WO-2007055513-A1 QUINAZOLINE DERIVATIVES AS A SIGNAL TRANSDUCTION INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2007-05-18 WO disclosed